Lee Ainslie's TXG Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 538,008 shares of 10x Genomics, Inc. (TXG) worth $48.61 M, representing 0.38% of the portfolio. First purchased in 2020-Q4, this short-term holding has been held for 5 quarters.
Based on 13F filings, Lee Ainslie has maintained this position in TXG for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 538,008 shares. Largest reduction occurred in Q2 2021, reducing 1,180 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +538,008 | New Buy | 538,008 | $90.36 |
| Q3 2021 | -822 | Sold Out | 0 | $0.00 |
| Q2 2021 | -1,180 | Reduce 58.94% | 822 | $195.86 |
| Q1 2021 | +623 | Add 45.18% | 2,002 | $180.82 |
| Q4 2020 | +1,379 | New Buy | 1,379 | $141.41 |
Lee Ainslie's 10x Genomics Investment FAQs
Lee Ainslie first purchased 10x Genomics, Inc. (TXG) in Q4 2020, acquiring 1,379 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held 10x Genomics, Inc. (TXG) for 5 quarters since Q4 2020.
Lee Ainslie's largest addition to 10x Genomics, Inc. (TXG) was in Q3 2026, adding 538,008 shares worth $48.61 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 538,008 shares of 10x Genomics, Inc. (TXG), valued at approximately $48.61 M.
As of the Q3 2026 filing, 10x Genomics, Inc. (TXG) represents approximately 0.38% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in 10x Genomics, Inc. (TXG) was 538,008 shares, as reported at the end of Q3 2026.